monensin and avoparcin

The aim of this study was to evaluate the effect of different antibiotics used as growth promoters on the control of porcine intestinal adenomatosis when administered in weaning, growing and fattening pig diets, according to Annex I of the European Union directive (70/524/EEC and its subsequent amendments to date) for the use of feed additives. On a farm with a previous history of proliferative enteropathy outbreaks, 648 weaned piglets (23 days old) were divided into nine experimental groups according to bodyweight and sex ratio, each group comprising four pens with 18 pigs in each pen. One group served the trial as a negative (unmedicated) control: another (the positive control) received monensin via feed at 100 p.p.m. up to the end of the growing phase (107 days old) and 50 p.p.m. up to slaughter age (156 days old). The remaining seven groups were offered feed with the addition of the following antibiotics: virginia-mycin (50-20 p.p.m.), avilamycin (40-20 p.p.m.), spiramycin (50-20 p.p.m.), zinc bacitracin (50-10 p.p.m.), avoparcin (40-20 p.p.m.), tylosin (40-20 p.p.m.) and salinomycin (60-30 p.p.m.), respectively. The performance of the pigs in the positive control group was very satisfying and among the highest in the trial, verifying earlier field studies. As a general conclusion it seems that all tested growth promoters had a beneficial effect compared with the untreated control, indicated by the decrease of mortality rate, the elimination of diarrhoeal incidence and the enhancement of growth performance, although the proliferative enteropathy control achieved by each substance was not always satisfactory. More specifically, the antibiotic growth promoters tested can be scaled according to their total efficacy as follows: 1. Salinomycin, tylosin, spiramycin; 2. Virginiamycin, zinc bacitracin, avilamycin; and 3. Avoparcin. Finally, it is considered that part of the growth promotion efficacy of the tested substances is due to their potential capacity to control porcine intestinal adenomatosis; thus, in future growth performance trials, the disease background of the trial farms must be examined, especially for porcine enteropathy challenges.

Topics: Abattoirs; Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacitracin; Bacterial Infections; Disease Outbreaks; Female; Food, Fortified; Glycopeptides; Greece; Growth Substances; Ileitis; Ileum; Intestinal Mucosa; Male; Monensin; Oligosaccharides; Pyrans; Spiramycin; Swine; Swine Diseases; Tylosin; Virginiamycin

The effects of the growth promoters avoparcin and avilamycin and the ionophore anticoccidials maduramicin, narasin and monensin on the growth of Clostridium perfringens (Cp) in the caeca and on performance of broiler chickens were tested in 2 experiments. The supplements were fed as single feed additives or in some combinations. No clinical signs or lesions caused by coccidia were observed in any of the studies. All supplements had an antibacterial effect on Cp and improved growth rate significantly. Carcass yield of birds fed growth promoters avilamycin or avoparcin was significantly higher compared with birds fed anticoccidials. These data indicate that, what concerns bird performance, during good hygienic conditions supplementation with antibiotic growth promoters may not be necessary when the diet is supplemented with an anticoccidial with antibacterial effects.

Topics: Animal Feed; Animals; Anti-Bacterial Agents; Cecum; Chickens; Clostridium Infections; Clostridium perfringens; Coccidiostats; Glycopeptides; Growth Substances; Ionophores; Lactones; Monensin; Oligosaccharides; Poultry Diseases; Pyrans; Random Allocation

1. An experiment was carried out with male broiler chicks to evaluate the combined effect of monensin (150 mg/kg) and the growth promoters (GPs) Zn bacitracin (BAC, 50 mg/kg), virginiamycin (VIR, 25 mg/kg) and avoparcin (AVO, 20 mg/kg) fed from 7 to 28 d of age on performance, utilisation of dietary nutrients, yield of defeathered eviscerated carcases (DEC) and size of various organs. The effect of the GPs in the monensin-unsupplemented diets fed up to 49 d of age on performance and carcase was also determined. 2. Monensin significantly (P < 0.05) depressed food intake, weight gain and food efficiency from 7 to 28 d of age. None of the GPs was able to counteract these effects. However, AVO slightly ameliorated them. AVO also significantly increased food intake and improved gain and food efficiency during 7 to 28, but not 28 to 49 or 7 to 49 d of age. VIR and BAC did not affect performance in either age period. 3. Monensin did not affect the utilisation of dietary dry matter, fat or energy, but it significantly decreased nitrogen utilisation. AVO improved nitrogen and fat utilisation and increased dietary AME(n) content. AME(n) was also increased by VIR. The utilisation of these nutrients was not affected by the interactions between monensin and the GPs. 4. Monensin did not affect yield of the DEC or the relative liver size at 31 d of age. It significantly increased the relative length of the small intestine (SI) and decreased its specific weight. AVO significantly increased yield at 31, but not at 53 d of age. BAC and VIR did not affect this variable. AVO and VIR, but not BAC, at both age periods reduced, at times significantly, the size, length and specific weight of the SI. 5. Our conclusions: BAC, VIR and AVO do not counteract the toxic effect of monensin. The effect of GPs in improving performance decreases and even disappears with age, while their effect in reducing the size of the SI is still evident in 49-d-old birds.

Topics: Animal Nutritional Physiological Phenomena; Animals; Anti-Bacterial Agents; Bacitracin; Chickens; Drug Interactions; Eating; Glycopeptides; Male; Monensin; Virginiamycin; Weight Gain

Bacteroides ruminicola M384 was grown in the presence of increasing concentrations of tetronasin, an ionophore that has been developed as a feed additive for ruminants. The resulting culture, B. ruminicola M384/TnR, was then maintained in medium containing 0.1 microgram tetronasin/ml. Growth of the parent strain was eliminated by the addition of 0.1 micrograms tetronasin/ml, but the growth rate of B. ruminicola M384/TnR, which grew more slowly than the parent strain, was unaffected by adding tetronasin. Bacteroides ruminicola M384/TnR retained its resistance to tetronasin even after repeated subculture in the absence of the ionophore, suggesting that a mutation had occurred. The absence of plasmids in individual colonies of B. ruminicola M384/TnR implied that the mutation was chromosomal. Bacteroides ruminicola M384/TnR was also more resistant to the ionophores monensin and lasalocid and, to a lesser degree, to the antibiotic avoparcin than B. ruminicola M384. Binding of [14C]tetronasin to B. ruminicola M384/TnR was lower than binding of the ionophore to the parent stain, and this difference was eliminated by washing cells with EDTA. The peptidolytic activity of B. ruminicola M384 towards triphenylalanine (Mr = 460) was unaffected in B. ruminicola M384/TnR, but the rate of breakdown tetraphenylalanine (Mr = 607) was decreased. This difference was also abolished by EDTA. It was concluded that growth of B. ruminicola in the presence of tetronasin resulted in a mutation affecting the permeability of the cell envelope, such that permeation of tetronasin and molecules of a similar size (Mr = 628) was decreased.

Topics: Animals; Anti-Bacterial Agents; Bacteroides; Cell Membrane Permeability; Chromosomes, Bacterial; Drug Resistance, Microbial; Furans; Glycopeptides; Ionophores; Lasalocid; Monensin; Mutation; Plasmids; Sheep

The influence of growth additives on the duration of salmonella shedding has been variously reported. The different conclusions reached were mainly because of the different experimental systems used. In this paper a naturally infected chicken model for evaluating this problem is described. It simulates commercial conditions and proved to be reproducible in 13 groups, each of 125 birds, over a two-year period.

Topics: Age Factors; Animals; Anti-Bacterial Agents; Cecum; Chickens; Cloaca; Female; Food Additives; Glycopeptides; Male; Monensin; Poultry Diseases; Salmonella; Salmonella Infections, Animal; Species Specificity

In two experiments (Experiments A and B) chickens experimentally infected with S. infantis at 7 days of age and fed diets containing both avoparcin (10 ppm) and monensin (90 ppm) showed a higher frequency of Salmonella-positive livers and higher caecal counts of Salmonella 1 and 2 weeks after challenge than similarly infected chickens fed only avoparcin (10 ppm). The results may indicate a synergistic action between the two drugs on the ability of chickens to withstand Salmonella infections.

Topics: Animals; Anti-Bacterial Agents; Cecum; Chickens; Female; Food Additives; Furans; Glycopeptides; Liver; Male; Monensin; Poultry Diseases; Salmonella; Salmonella Infections, Animal

One-hundred and fifty crossbred yearling-heifers, averaging 264 +/- 17 kg were fed a 77% barley diet for 140 days to evaluate the effect of 0, 33, 49.5 and 66 ppm avoparcin and 33 ppm monensin on growth rate, feed efficiency, carcass quality and ruminal volatile fatty acid (VFA) concentration. Heifers were allotted by weight to 25 pens (six head per pen) in a randomized complete block design of five treatments and five replicates per treatment. On day 140, rumen fluid was obtained from a randomly selected replicate of six heifers from each treatment for VFA analysis. Carcass data and liver samples were obtained at slaughter on day 147. All avoparcin-fed cattle consumed less feed per unit gain (P less than .05) than did those in the control group. Feed intakes of the monensin-fed heifers and the heifers fed 49.5 ppm avoparcin were lower (P less than .05) than those of the control group. There were no differences (P greater than .05) between treatments for measured carcass, liver or rumen parameters.

Topics: Animals; Anti-Bacterial Agents; Body Weight; Cattle; Fatty Acids, Volatile; Female; Furans; Glycopeptides; Monensin

Groups of 33 chickens were fed continuously on diets containing feed additives that are employed commercially for a variety of purposes, and were infected orally when 4 days old with a nalidixic acid-resistant mutant of Salmonella typhimurium. The amount of S. typhimurium organisms excreted in their faeces was estimated by culturing them at intervals and in a standard manner on brilliant green agar containing sodium nalidixate; when the chickens were killed their caecal contents were examined by the same technique.Avoparcin and lincomycin, like nitrovin and tylosin (Smith & Tucker, 1975b), favoured colonization of the alimentary tract by the S. typhimurium organisms as shown by the fact that the chickens to which they were fed excreted these organisms in their faeces in higher concentration and for longer periods of time than did chickens fed on non-medicated diets. Amprolium, monensin, dimetridazole, arsenilic acid and nitro-hydroxyphenylarsonate had no obvious effect on the salmonella excretion pattern.When only five chickens in each group were experimentally infected so that the effect of the feed additives on infections acquired by contact could be monitored, avoparcin, lincomycin, nitrovin and tylosin again favoured colonization of the alimentary tract with the S. typhimurium organisms and so did dimetridazole. Arsenilic acid, in contrast, hindered the development of infection. Amprolium, monensin and nitro-hydroxyphenylarsonate were without obvious effect.Many of the chickens that were fed on diets that favoured S. typhimurium colonization, but not those fed on non-medicated diets, were still excreting S. typhimurium organisms in their faeces when they were killed at 56 days of age, the age at which broiler chickens kept under commercial conditions are usually slaughtered.

Topics: Amprolium; Animal Feed; Animals; Anti-Bacterial Agents; Arsenicals; Chickens; Digestive System; Dimetridazole; Feces; Glycopeptides; Leucomycins; Lincomycin; Monensin; Nitrovin; Poultry Diseases; Salmonella typhimurium